BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 15368185)

  • 1. [High infection risk in chronic gastrointestinal or living diseases. Early vaccination is the best prevention].
    Stiefelhagen P
    MMW Fortschr Med; 2004 Nov; 146(46):12, 14. PubMed ID: 15600035
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenicity and safety of an inactivated hepatitis a vaccine administered concomitantly with a pneumococcal conjugate vaccine in healthy children 15 months of age.
    Trofa AF; Levin M; Marchant CD; Hedrick J; Blatter MM
    Pediatr Infect Dis J; 2008 Jul; 27(7):658-60. PubMed ID: 18536623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of antiretroviral therapy on immunogenicity of simultaneous vaccinations against influenza, pneumococcal disease and hepatitis A and B in human immunodeficiency virus positive individuals.
    Horster S; Laubender RP; Lehmeyer L; Ankerst DP; Eberle J; Reinert R; Imöhl M; van der Linden M; Schweiger B; Bogner JR
    J Infect; 2010 Dec; 61(6):484-91. PubMed ID: 20875454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Vaccination requirements in patients with gastroenterological diseases (hepatitis A and B, pneumococcal and meningococcal vaccination)].
    Weinke T; Güthoff W; Jahn HU
    Dtsch Med Wochenschr; 2004 Sep; 129 Suppl 2():S104-6. PubMed ID: 15368185
    [No Abstract]   [Full Text] [Related]  

  • 5. Routine vaccines across the life span, 2005.
    Zimmerman RK; Middleton DB; Burns IT; Clover RD; Kimmel SR
    J Fam Pract; 2005 Jan; 54(1 Suppl):S9-26. PubMed ID: 15623396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV).
    Knuf M; Szenborn L; Moro M; Petit C; Bermal N; Bernard L; Dieussaert I; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S97-S108. PubMed ID: 19325452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the efficacy, immunogenicity and tolerability of a combined hepatitis A and B vaccine.
    Van Damme P; Van Herck K
    Expert Rev Vaccines; 2004 Jun; 3(3):249-67. PubMed ID: 15176942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines.
    Chevallier B; Vesikari T; Brzostek J; Knuf M; Bermal N; Aristegui J; Borys D; Cleerbout J; Lommel P; Schuerman L
    Pediatr Infect Dis J; 2009 Apr; 28(4 Suppl):S109-18. PubMed ID: 19325447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bivalent inactivated hepatitis A and recombinant hepatitis B vaccine.
    Beran J
    Expert Rev Vaccines; 2007 Dec; 6(6):891-902. PubMed ID: 18377352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against hepatitis A and B: developments, deployment and delusions.
    Zuckerman JN
    Curr Opin Infect Dis; 2006 Oct; 19(5):456-9. PubMed ID: 16940869
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.